China301211.CS▲
Hendi Pharmaceutical's Ibuprofen Arginine Granules Receive Drug Registration Certificate
Hendi Pharmaceutical announced that the company recently received the Drug Registration Certificate approved and issued by the National Medical Products Administration. Ibuprofen Arginine Granules have been approved for registration and are to be managed as a Class A over-the-counter drug. The drug is indicated for toothache, menstrual pain, headache, and fever caused by influenza. The company stated that this approval marks its qualification to sell the product in the domestic market and further enriches its product line.
301211.CS · Regulation · Positive Received Drug Registration Certificate from NMPA for Ibuprofen Arginine Granules, gaining domestic market sales qualification and enriching its product line.